kiroi.org

KIROI - Artificial Intelligence Return on Invest
The AI strategy for decision-makers and managers

Business excellence for decision-makers & managers by and with Sanjay Sauldie

KIROI - Artificial Intelligence Return on Invest: The AI strategy for decision-makers and managers

Start » Cost-Benefit Analysis: AI in Healthcare – A Worthwhile Investment?

12 January 2026

Cost-Benefit Analysis: AI in Healthcare – A Worthwhile Investment?

Digital transformation Digitalisation of hospitals Health management AI in healthcare Artificial Intelligence Special Topics Economy & Finance

Executive Summary

Artificial intelligence (AI) is transforming healthcare by increasing efficiency, improving diagnostic accuracy, and optimising patient care. The implementation of AI solutions in hospitals and clinics requires a careful cost-benefit analysis that goes beyond initial investments and considers the long-term return on investment (ROI). The AI ROI strategy offers a robust framework for this, quantifying and strategically anchoring the measurable added value of AI applications.

Strategic Classification: AI as a Driver of Efficiency in Healthcare

Healthcare systems worldwide are under considerable pressure to increase efficiency while simultaneously ensuring the quality of care. AI technologies offer transformative potential for this, ranging from more precise diagnostics and personalised medicine to the optimisation of administrative processes. According to PwC, AI could generate a global GDP increase of up to US$15.7 trillion by 2030, with the healthcare sector playing a key role [1]. A study by Accenture forecasts that AI in healthcare could achieve annual savings of up to US$150 billion by 2026, primarily through process optimisation and improved outcomes [2]. These figures underscore the necessity of viewing AI not as an optional add-on, but as a core strategic investment.

The KIROI Strategy as an Evaluation Framework

Sanjay Sauldie's KIROI (Artificial Intelligence Return on Investment) strategy offers a systematic approach to evaluating the economic benefits of AI investments. It focuses on quantifying added value and ensuring a positive ROI. In the context of healthcare, this means not only considering the direct costs of AI implementation but also capturing indirect savings and value creation. These include reduced hospital stays, optimised staff deployment, improved patient safety, and enhanced treatment quality. The strategy emphasises the need to define clear metrics and KPIs to make the success of AI projects measurable.

Cost analysis: investments in AI infrastructure and expertise

The introduction of AI in healthcare involves significant initial investment. These include:

Hardware and infrastructure Powerful servers, cloud computing resources, and database systems are essential for training and operating AI models.
Software Licences and Development: Costs for specialised AI software, platforms, and, if applicable, custom algorithm development.
Data Management and Integration The preparation, anonymisation, and integration of large volumes of heterogeneous patient data is complex and resource-intensive.
Personnel training and recruitment Hospitals need staff with AI skills (data scientists, AI engineers) or must provide comprehensive training for existing staff. A survey by IBM shows that 43% of companies worldwide are struggling to find AI talent [3].
Regulatory Compliance and Cybersecurity: Compliance with strict data protection regulations (e.g. GDPR, HIPAA) and ensuring data security require additional investment.

A 2020 study by Deloitte estimated the average implementation costs for an AI solution in healthcare to be several hundred thousand to millions of euros, depending on scope and complexity [4]. However, these costs must be considered in relation to the potential returns.

Benefit Analysis: Measurable Added Value through AI Applications

The advantages of AI in healthcare are diverse and generate a significant ROI:

Increasing efficiency in diagnosis and treatment

AI-powered diagnostic systems, for example in radiology or pathology, can speed up the analysis of images and tissue samples and improve accuracy. A meta-analysis by Google Health showed that AI systems can increase sensitivity by 9.4 percentage points and specificity by 5.7 percentage points compared to human radiologists in the early detection of breast cancer [5]. This leads to earlier diagnoses, better treatment outcomes and reduced follow-up costs.

Optimisation of administrative and operational processes

AI automates routine tasks such as scheduling, patient registration and billing. This takes the pressure off staff and reduces administrative errors. Chatbots and virtual assistants improve patient service and reduce the time and effort required to handle enquiries. In the field of supply chain management, AI optimises the stock management of medicines and medical devices, minimises bottlenecks and reduces waste. McKinsey estimates that the automation of administrative tasks in the healthcare sector could save up to 20% of working time [6].

Personalised medicine and drug development

AI analyses large datasets (genomic data, patient records, clinical trials) for the development of personalised treatment plans and the identification of new active ingredients. This accelerates drug development and improves therapeutic success, leading to a reduction in healthcare costs in the long term. IBM Watson Health, for example, has been used to support cancer treatment by suggesting evidence-based therapy options to doctors [7].

Improving patient safety and satisfaction

AI systems can identify risk factors for complications early on, reduce medication errors, and improve patient monitoring. This enhances patient safety and contributes to patient satisfaction, which in turn strengthens the institution's reputation and promotes patient loyalty.

Market Perspective: Growth and Acceptance of AI in Healthcare

The global market for AI in healthcare is growing rapidly. According to Grand View Research, the market was valued at US$15.1 billion in 2022 and is projected to achieve a compound annual growth rate (CAGR) of 37.0% by 2030 [8]. This growth is driven by the rising demand for more efficient healthcare solutions, technological advancements and increasing data availability. Acceptance of AI among healthcare professionals and patients is growing, but it still requires transparent communication and the demonstration of concrete benefits.

Challenges and risk management

Despite the enormous potential, challenges remain. These include data quality, ethical concerns, end-user acceptance, and integration into existing IT systems. The KIROI strategy addresses these points by providing for iterative implementation and continuous success monitoring. Proactive risk management, taking into account data protection, ethical, and technical aspects, is crucial for long-term success.

Key Takeaways

AI is a strategic investment in healthcare, enabling significant efficiency gains and quality improvements.
The KIROI strategy offers a structured framework for quantifying the return on investment of AI projects.
Initial costs for hardware, software, data management, and personnel are more than compensated for by long-term savings and added value in diagnosis, treatment, and administration.
AI applications improve patient safety, satisfaction, and enable personalised medicine.
Despite challenges such as data quality and acceptance, the benefits outweigh the drawbacks, as evidenced by the rapidly growing market for AI in healthcare.